|

Dengue 1,2,3,4 (attenuated) vaccine Clinical Trials

1 actively recruiting trial

Also known as: Butantan-DV, TetraVax-DV-TV003

Pipeline

Phase 4: 1

Top Sponsors

  • University of Sao Paulo General Hospital1

Indications

  • Juvenile Systemic Lupus Erythematosus1
  • Idiopathic Inflammatory Myopathies (IIMs)1
  • Granulomatosis With Polyangiitis1
  • Microscopic Polyangiitis1
  • Takayasu Arteritis1

Other1 trial

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.